APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Equine Rhinopneumonitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Equine Rhinopneumonitis Vaccine Industry Growth and Trends Forecast to 2032

Report ID 17398916012 January 202696 pages

Choose your research edition.

Industry ResearchEquine Rhinopneumonitis Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Rhinopneumonitis Vaccine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Equine Rhinopneumonitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Rhinopneumonitis Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Rhinopneumonitis Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Equine Rhinopneumonitis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Equine Rhinopneumonitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Equine Rhinopneumonitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Equine Rhinopneumonitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Equine Rhinopneumonitis Vaccine include Merck, Zoetis, Santa Cruz Animal Health, Nisseiken Co., Ltd. and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Equine Rhinopneumonitis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Equine Rhinopneumonitis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Equine Rhinopneumonitis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Equine Rhinopneumonitis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Equine Rhinopneumonitis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Equine Rhinopneumonitis Vaccine Market by Company

Merck

Zoetis

Santa Cruz Animal Health

Nisseiken Co., Ltd.

Boehringer Ingelheim

Equine Rhinopneumonitis Vaccine Segment by Type

Live

Inactivated

Equine Rhinopneumonitis Vaccine Segment by Application

Veterinary Pharmacy

Online Sale

Others

Equine Rhinopneumonitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Rhinopneumonitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Rhinopneumonitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Rhinopneumonitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Equine Rhinopneumonitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Equine Rhinopneumonitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Table 2. Major Company of Inactivated Table 3. Global Equine Rhinopneumonitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (Units) Table 5. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Equine Rhinopneumonitis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Equine Rhinopneumonitis Vaccine Sales by Type (2027-2032) & (Units) Table 10. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Equine Rhinopneumonitis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Equine Rhinopneumonitis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (Units) Table 15. North America Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (Units) Table 17. Europe Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (Units) Table 21. Latin America Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Equine Rhinopneumonitis Vaccine Industry Trends Table 25. Equine Rhinopneumonitis Vaccine Industry Drivers Table 26. Equine Rhinopneumonitis Vaccine Industry Opportunities and Challenges Table 27. Equine Rhinopneumonitis Vaccine Industry Restraints Table 28. Global Equine Rhinopneumonitis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Equine Rhinopneumonitis Vaccine Sales by Company (2021-2026) & (Units) Table 31. Global Equine Rhinopneumonitis Vaccine Sales Share by Company (2021-2026) Table 32. Global Equine Rhinopneumonitis Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Equine Rhinopneumonitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Equine Rhinopneumonitis Vaccine Major Company Production Sites and Headquarters Table 35. Global Equine Rhinopneumonitis Vaccine Company, Product Type & Application Table 36. Global Equine Rhinopneumonitis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Equine Rhinopneumonitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Equine Rhinopneumonitis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Equine Rhinopneumonitis Vaccine Sales by Region (2021-2026) & (Units) Table 41. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Equine Rhinopneumonitis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Equine Rhinopneumonitis Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Equine Rhinopneumonitis Vaccine Sales by Region (2027-2032) & (Units) Table 46. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Equine Rhinopneumonitis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Equine Rhinopneumonitis Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Equine Rhinopneumonitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (Units) Table 52. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Equine Rhinopneumonitis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Equine Rhinopneumonitis Vaccine Sales by Application (2027-2032) & (Units) Table 57. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Equine Rhinopneumonitis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Equine Rhinopneumonitis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (Units) Table 62. North America Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (Units) Table 64. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (Units) Table 68. Latin America Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Equine Rhinopneumonitis Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Equine Rhinopneumonitis Vaccine Product Portfolio Table 75. Merck Recent Development Table 76. Zoetis Company Information Table 77. Zoetis Business Overview Table 78. Zoetis Equine Rhinopneumonitis Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zoetis Equine Rhinopneumonitis Vaccine Product Portfolio Table 80. Zoetis Recent Development Table 81. Santa Cruz Animal Health Company Information Table 82. Santa Cruz Animal Health Business Overview Table 83. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Portfolio Table 85. Santa Cruz Animal Health Recent Development Table 86. Nisseiken Co., Ltd. Company Information Table 87. Nisseiken Co., Ltd. Business Overview Table 88. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Portfolio Table 90. Nisseiken Co., Ltd. Recent Development Table 91. Boehringer Ingelheim Company Information Table 92. Boehringer Ingelheim Business Overview Table 93. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Portfolio Table 95. Boehringer Ingelheim Recent Development Table 96. North America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 97. North America Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (Units) Table 98. North America Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2021-2026) Table 99. North America Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 100. North America Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. North America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Equine Rhinopneumonitis Vaccine Market Share by Country (2021-2026) Table 104. North America Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Equine Rhinopneumonitis Vaccine Market Share Forecast by Country (2027-2032) Table 106. Europe Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 107. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (Units) Table 108. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2021-2026) Table 109. Europe Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 110. Europe Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Equine Rhinopneumonitis Vaccine Market Share by Country (2021-2026) Table 114. Europe Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Equine Rhinopneumonitis Vaccine Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (Units) Table 118. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 120. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Share by Country (2021-2026) Table 124. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Share Forecast by Country (2027-2032) Table 126. Latin America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 127. Latin America Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (Units) Table 128. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2021-2026) Table 129. Latin America Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 130. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Equine Rhinopneumonitis Vaccine Market Share by Country (2021-2026) Table 134. Latin America Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Equine Rhinopneumonitis Vaccine Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (Units) Table 138. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 140. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Share by Country (2021-2026) Table 144. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Equine Rhinopneumonitis Vaccine Distributors List Table 149. Equine Rhinopneumonitis Vaccine Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Equine Rhinopneumonitis Vaccine Image Figure 2. Global Equine Rhinopneumonitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Rhinopneumonitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Rhinopneumonitis Vaccine Sales (2021-2032) & (Units) Figure 5. Live Image Figure 6. Global Live Sales YoY Growth (2021-2032) & (Units) Figure 7. Inactivated Image Figure 8. Global Inactivated Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Equine Rhinopneumonitis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Equine Rhinopneumonitis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Equine Rhinopneumonitis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Veterinary Pharmacy Image Figure 24. Global Veterinary Pharmacy Sales YoY Growth (2021-2032) & (Units) Figure 25. Online Sale Image Figure 26. Global Online Sale Sales YoY Growth (2021-2032) & (Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Equine Rhinopneumonitis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Equine Rhinopneumonitis Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Equine Rhinopneumonitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Equine Rhinopneumonitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Equine Rhinopneumonitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Equine Rhinopneumonitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Equine Rhinopneumonitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Equine Rhinopneumonitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Equine Rhinopneumonitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Equine Rhinopneumonitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Equine Rhinopneumonitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Equine Rhinopneumonitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Equine Rhinopneumonitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Equine Rhinopneumonitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Equine Rhinopneumonitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Equine Rhinopneumonitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Equine Rhinopneumonitis Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Equine Rhinopneumonitis Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Live
  • Inactivated
Applications
  • Veterinary Pharmacy
  • Online Sale
  • Others
Companies covered
  • Merck
  • Zoetis
  • Santa Cruz Animal Health
  • Nisseiken Co., Ltd.
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Equine Rhinopneumonitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Equine Rhinopneumonitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Equine Rhinopneumonitis Vaccine Market by Type
  6. 1.3.1 Live
  7. 1.3.2 Inactivated
  8. 1.4 Global Equine Rhinopneumonitis Vaccine Market Size by Type
  9. 1.4.1 Global Equine Rhinopneumonitis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Equine Rhinopneumonitis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Equine Rhinopneumonitis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Equine Rhinopneumonitis Vaccine Industry Trends
  2. 2.2 Equine Rhinopneumonitis Vaccine Industry Drivers
  3. 2.3 Equine Rhinopneumonitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Equine Rhinopneumonitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Equine Rhinopneumonitis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Equine Rhinopneumonitis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Equine Rhinopneumonitis Vaccine Price (2021-2026)
  4. 3.4 Global Equine Rhinopneumonitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Equine Rhinopneumonitis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Equine Rhinopneumonitis Vaccine Company, Product Type & Application
  7. 3.7 Global Equine Rhinopneumonitis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Equine Rhinopneumonitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Equine Rhinopneumonitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Equine Rhinopneumonitis Vaccine Tier 1, Tier 2, and Tier 3
4 Equine Rhinopneumonitis Vaccine Regional Status and Outlook
  1. 4.1 Global Equine Rhinopneumonitis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Equine Rhinopneumonitis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Equine Rhinopneumonitis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Equine Rhinopneumonitis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Equine Rhinopneumonitis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Equine Rhinopneumonitis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Equine Rhinopneumonitis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Equine Rhinopneumonitis Vaccine by Application
  1. 5.1 Equine Rhinopneumonitis Vaccine Market by Application
  2. 5.1.1 Veterinary Pharmacy
  3. 5.1.2 Online Sale
  4. 5.1.3 Others
  5. 5.2 Global Equine Rhinopneumonitis Vaccine Market Size by Application
  6. 5.2.1 Global Equine Rhinopneumonitis Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Equine Rhinopneumonitis Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Equine Rhinopneumonitis Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Equine Rhinopneumonitis Vaccine Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Equine Rhinopneumonitis Vaccine Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Santa Cruz Animal Health
  14. 6.3.1 Santa Cruz Animal Health Company Information
  15. 6.3.2 Santa Cruz Animal Health Business Overview
  16. 6.3.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Portfolio
  18. 6.3.5 Santa Cruz Animal Health Recent Developments
  19. 6.4 Nisseiken Co., Ltd.
  20. 6.4.1 Nisseiken Co., Ltd. Company Information
  21. 6.4.2 Nisseiken Co., Ltd. Business Overview
  22. 6.4.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Portfolio
  24. 6.4.5 Nisseiken Co., Ltd. Recent Developments
  25. 6.5 Boehringer Ingelheim
  26. 6.5.1 Boehringer Ingelheim Company Information
  27. 6.5.2 Boehringer Ingelheim Business Overview
  28. 6.5.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Portfolio
  30. 6.5.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Equine Rhinopneumonitis Vaccine Sales by Country
  2. 7.1.1 North America Equine Rhinopneumonitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Equine Rhinopneumonitis Vaccine Market Size by Country
  6. 7.2.1 North America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Equine Rhinopneumonitis Vaccine Sales by Country
  2. 8.1.1 Europe Equine Rhinopneumonitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Equine Rhinopneumonitis Vaccine Market Size by Country
  6. 8.2.1 Europe Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Equine Rhinopneumonitis Vaccine Sales by Country
  2. 10.1.1 South America Equine Rhinopneumonitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Equine Rhinopneumonitis Vaccine Market Size by Country
  6. 10.2.1 South America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Equine Rhinopneumonitis Vaccine Value Chain Analysis
  2. 12.1.1 Equine Rhinopneumonitis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Equine Rhinopneumonitis Vaccine Production Mode & Process
  7. 12.2 Equine Rhinopneumonitis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Equine Rhinopneumonitis Vaccine Distributors
  10. 12.2.3 Equine Rhinopneumonitis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst